Promise provides labelled proteins for the absolute quantification of proteins in biological samples. Innovative in the fields of therapeutic proteins, biomarkers and quality controls, Promise offers a brand new prospective for your business. Promise brings you the most powerful quantitative proteomics approaches, Stable Isotopically Labelled proteins (SIL-proteins), which are described as the gold standards for protein quantification : your proteins are specifically quantified with the highest levels of accuracy. With this wealth of experience, Promise helps its customers in the development of customized solutions for their projects: - Biomarkers evaluation & validation -Pharmakokinetics studies of your biotherapeutics, stability studies of your proteins Capitalising on its unique know-how in the production of internal standards for protein assays and its recognised expertise in mass spectrometry based quantification methods, today Promise Proteomics is making its skills available to aid health care professionals and patients through its mAbXmise kits. The range developed and commercialised by Promise Proteomics today comprises two products: mAbXmise Inflammation kit designed to monitor therapeutic antibodies prescribed to treat inflammatory diseases; and a second kit, mAbXmise Oncology, that targets antibodies prescribed in cancer treatment. Legal mention : mAbXmise kits are in vitro diagnostic medical devices intended for healthcare professionals. These are monoclonal antibody quantification kits: see the specific instructions for more information